Literature DB >> 31705405

Influence of wide opening of the lateral ventricle on survival for supratentorial glioblastoma patients with radiotherapy and concomitant temozolomide-based chemotherapy.

Taiichi Saito1, Yoshihiro Muragaki2,3, Takashi Maruyama2,3, Takashi Komori4, Masayuki Nitta2, Shunsuke Tsuzuki2, Atsushi Fukui2, Takakazu Kawamata2.   

Abstract

The prognosis for glioblastoma (GBM) varies among patients. Ventricular opening during surgery has been reported as a prognostic factor for GBM patients, but the influence of ventricular opening itself on patient prognosis remains controversial. We presumed that the degree of ventricular opening would correlate with the degree of subventricular zone (SVZ) resection and with prognosis in GBM patients. This study therefore investigated whether the degree of ventricular opening correlates with prognosis in GBM patients treated with the standard protocol of chemo-radiotherapy. Participants comprised 111 patients with newly diagnosed GBM who underwent surgery and received postoperative radiotherapy and temozolomide-based chemotherapy from 2005 to 2018. We classified 111 patients into "No ventricular opening (NVO)", "Ventricular opening, small (VOS; distance < 23.2 mm)", and "Ventricular opening, wide (VOW; distance ≥ 23.2 mm)" groups. We evaluated the relationship between degree of ventricular opening and prognosis using survival analyses that included other clinicopathological factors. Log-rank testing revealed age, Karnofsky performance status (KPS), extent of resection, O6-methylguanine-DNA methyltransferase (MGMT) status, isocitrate dehydrogenase (IDH)1 mutation, and degree of ventricular opening correlated significantly with overall survival. Multivariate analysis identified the degree of ventricular opening (small vs. wide) as the most significant prognostic factor (hazard ratio = 3.674; p < 0.0001). We demonstrated that wide opening of the lateral ventricle (LV) contributes to longer survival compared with small opening among GBM patients. Our results indicate that wide opening of the LV may correlate with the removal of a larger proportion of tumor stem cells from the SVZ.

Entities:  

Keywords:  Glioblastoma; Lateral ventricle; Prognosis; Subventricular zone; Temozolomide

Mesh:

Substances:

Year:  2019        PMID: 31705405     DOI: 10.1007/s10143-019-01185-2

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  28 in total

1.  Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.

Authors:  Xing Gong; Philip H Schwartz; Mark E Linskey; Daniela A Bota
Journal:  Neurology       Date:  2011-02-23       Impact factor: 9.910

2.  Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.

Authors:  Atsushi Fukui; Yoshihiro Muragaki; Taiichi Saito; Takashi Maruyama; Masayuki Nitta; Soko Ikuta; Takakazu Kawamata
Journal:  World Neurosurg       Date:  2016-10-29       Impact factor: 2.104

3.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

4.  Complications of ventricular entry during craniotomy for brain tumor resection.

Authors:  Jessin K John; Adam M Robin; Aqueel H Pabaney; Richard A Rammo; Lonni R Schultz; Neema S Sadry; Ian Y Lee
Journal:  J Neurosurg       Date:  2016-11-04       Impact factor: 5.115

5.  The Prognostic Impact of Ventricular Opening in Glioblastoma Surgery: A Retrospective Single Center Analysis.

Authors:  Felix Behling; Marlene Kaltenstadler; Susan Noell; Jens Schittenhelm; Benjamin Bender; Franziska Eckert; Ghazaleh Tabatabai; Marcos Tatagiba; Marco Skardelly
Journal:  World Neurosurg       Date:  2017-07-18       Impact factor: 2.104

6.  Relationship of glioblastoma multiforme to the subventricular zone is associated with survival.

Authors:  Nazia F Jafri; Jennifer L Clarke; Vivian Weinberg; Igor J Barani; Soonmee Cha
Journal:  Neuro Oncol       Date:  2012-10-24       Impact factor: 12.300

7.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

8.  Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.

Authors:  Branislav Jeremic; Biljana Milicic; Danica Grujicic; Aleksandar Dagovic; Jasna Aleksandrovic
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-15       Impact factor: 4.553

9.  Impact of Multifocality and Molecular Markers on Survival of Glioblastoma.

Authors:  Yahya Ahmadipour; Ramazan Jabbarli; Oliver Gembruch; Daniela Pierscianek; Marvin Darkwah Oppong; Philipp Dammann; Karsten Wrede; Neriman Özkan; Oliver Müller; Ulrich Sure; Nicolai El Hindy
Journal:  World Neurosurg       Date:  2018-10-19       Impact factor: 2.104

10.  A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?

Authors:  Sebastian Adeberg; Tilman Bostel; Laila König; Thomas Welzel; Juergen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2014-04-23       Impact factor: 3.481

View more
  1 in total

1.  Mucosal thickening of the maxillary sinus is frequently associated with diffuse glioma patients and correlates with poor survival prognosis of GBM patients: comparative analysis to meningioma patients.

Authors:  Taiichi Saito; Yoshihiro Muragaki; Takashi Maruyama; Kayoko Abe; Takashi Komori; Kosaku Amano; Seiichiro Eguchi; Masayuki Nitta; Shunsuke Tsuzuki; Atsushi Fukui; Takakazu Kawamata
Journal:  Neurosurg Rev       Date:  2021-02-03       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.